AERPIO PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01 Other Events.

On January 5, 2021, Aerpio Pharmaceuticals, Inc. issued a press release titled "Aerpio Announces Strategic Review after Topline Results from Razuprotafib Glaucoma Phase 2 Trial." A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 8.01 by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits



Exhibit No.                                  Description

99.1                Press release issued by Aerpio Pharmaceuticals, Inc. on
                  January 5, 2021.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses